| For: | Elkhattib I, Raafat KW, Elsayed B, Elnaggar M. Chronic hepatitis C and the risk for atherosclerotic and cardiomyopathic heart disease. World J Hepatol 2025; 17(8): 108678 [PMID: 40901587 DOI: 10.4254/wjh.v17.i8.108678] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v17/i8/108678.htm |
| Number | Citing Articles |
| 1 |
Mohammed Zohery, Sarah Jahangir, Hamed Carter Jenna, Shiza Sarfraz, Hadeera Ali, Muhammad Raza, Taha Rafiq, Dushyant Singh Dahiya, Vinay Jahagirdar, Hassam Ali. Thrombotic risk in hepatitis C: Interplay between hepatic dysfunction, viral-driven inflammation, and cardiovascular consequences. World Journal of Virology 2025; 14(4): 113217 doi: 10.5501/wjv.v14.i4.113217
|
| 2 |
Caleb Hammons, Athul Mohanram, Preston Nguyen, Wenting Lu, Betty Jacobs, Xian Chang Li, Zhiqiang Zhang, Junji Xing. Antiviral innate immunity in myocarditis: mechanisms and emerging therapeutics. Experimental & Molecular Medicine 2026; doi: 10.1038/s12276-026-01822-z
|
| 3 |
Olga V. Masalova, Ekaterina I. Lesnova, Vyacheslav V. Kozlov, Vladimir T. Valuev-Elliston, Kristina Yu. Permyakova, Natalya E. Fedorova, Tatyana N. Nikolaeva, Alexander V. Pronin, Alexander V. Ivanov, Alla A. Kushch. Immunogenicity of a Candidate Hepatitis C Vaccine Based on Non-Structural DNA-Protein Sequences and a Novel Complex Adjuvant. Vaccines 2026; 14(7) doi: 10.3390/vaccines14070640
|
| 4 |
Yiran Wang, Yanan Bian, Dongwei Han, Liwen Wang, Bojia Li, Ying Fang, Xiaoyang Hu. Banxia Xiexin Decoction attenuates atherosclerosis by reducing mitochondrial damage via the p62/SLC7A11/GPX4 pathway. Journal of Ethnopharmacology 2027; 373 doi: 10.1016/j.jep.2026.122253
|
| 5 |
Ismail Balaban, Seda Tanyeri Uzel, Elif Caglayan, Dogancan Ceneli, Halit Eminoglu, Barkin Kultursay, Mustafa Ferhat Keten, Kadir Biyikli. Association Between Hepatitis C Virus Infection and SYNTAX Score in Patients with ST-Segment Elevation Myocardial Infarction: A Propensity Score-Matched Analysis. Journal of Clinical Medicine 2026; 15(11) doi: 10.3390/jcm15114180
|